The table below is a review of notable updates that occurred in January 2025 for investigational products in development.

Bolt Biotherapeutics, Inc., announced today that the target of their worldwide co-development collaboration with Toray Industries, Inc. is Caprin-1, a novel cancer target discovered by Toray. The ...

As we observe World Cancer Day today, let us look at some of the trends in cancer therapeutics expected to improve cancer ...

A thyroglobulin antibody (TgAb) test looks for certain antibodies that attack the thyroid. The presence of TbAb in high levels may indicate that someone has an autoimmune condition. To conduct a ...

LifeArc Ventures, which invests in innovative early-stage life science companies as part of LifeArc, today announced substantial progress in 2024, with three new investments, several follow-on ...

Myelin oligodendrocyte glycoprotein antibody disease (MOGAD) is a condition of the nervous system that can be managed with lifestyle modifications or medications, depending on your individual needs.

Luckily, as with most modern problems, there's an equally modern solution. Enter Loop Earplugs. You might have seen them nestled in your colleague's ears complementing a cute AF ear stack ...

As maturity of the developed solution increases, we need a more representative real-world 'hardware-in-the-loop' testing in visual conditions resembling space. GRALS enables such test conditions ...

Saliva-based diagnostics have emerged as a transformative approach in medical testing, offering a non-invasive and efficient alternative to blood sampling. However, the complexity of saliva, which ...

One of the biggest TCG tournaments happened at the recent BCGFest in Orlando. Let's see who were the big winners in the Digimon tournament.

Traditionally, antibody epitopes on target proteins have been identified by performing deletion ... Notably, regardless of the Myc scFv variant, the CDR loop RMSD improved by more than 1Å when the ...

Today, a brief rundown of news involving Intellia Therapeutics and ArriVent BioPharma, as well as updates from Atara Biotherapeutics, Amylyx Pharmaceuticals and InnoCare Pharma that you may have ...